Clinical trial
A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma: Phase 2 Trial of Clinical Applications
NCT04814615 is registered in ClinicalTrials.gov with Hoag Memorial Hospital Presbyterian as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma: Phase 2 Trial of Clinical Applications
- Lead sponsor
- Hoag Memorial Hospital Presbyterian
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- March 8, 2021
- Completion date
- March 15, 2026
- Enrollment
- 60 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.